Table 2.
Characteristics of study participants by treatment group
| Treatment group* | |||
|---|---|---|---|
| Control (n = 900) | Implementation (n = 834) | p-value | |
| Country | |||
| Austria | 308 (34.2) | 277 (33.2) | – |
| Italy | 171 (19.0) | 164 (19.7) | |
| Norway | 165 (18.3) | 170 (20.4) | |
| Spain | 128 (14.2) | 153 (18.4) | |
| Sweden | 128 (14.2) | 70 (8.4) | |
| Number of centres | 115 | 131 | – |
| Age, years | 52.6 (15.1) | 54.2 (15.4) | 0.03 |
| Sex, male | 427 (47.4) | 386 (46.3) | 0.63 |
| Current smokers | 235 (26.1) | 233 (27.9) | 0.39 |
| Current drinkers | 343 (38.1) | 276 (33.1) | 0.03 |
| Date of diagnosis† | |||
| Before 2009 | 349 (55.5) | 281 (53.6) | 0.49 |
| 2009 | 277 (44.3) | 243 (46.4) | |
Values are number of patients (%), except for age [mean (SD)].
*
Control = usual care; implementation = structured treatment pathway.
†
Based on n = 1149 patients with available date of diagnosis. 2009 was the cut-off as this coincided with when the studies were conducted.